The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
IntroductionThe COVID-19 pandemic dramatically disrupts health care for patients with chronic diseases including chronic spontaneous urticaria (CSU). As of now, it is unknown if the effects of the pandemic in CSU are different than in other chronic diseases. We also do not know, if different groups...
Guardado en:
Autores principales: | Huzeyfe Kulu, Mustafa Atasoy, Kemal Özyurt, Marcus Maurer, Atıl Avcı, Muhammet Reşat Akkuş, Ragıp Ertaş |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2235f84cafb444e08816173bda9b54e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska MT
Publicado: (2016) -
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective
por: Catherine King, et al.
Publicado: (2021) -
Biomarkers of Gut Microbiota in Chronic Spontaneous Urticaria and Symptomatic Dermographism
por: Runqiu Liu, et al.
Publicado: (2021) -
Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report
por: Hyuk Soon Kim, et al.
Publicado: (2021) -
Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
por: Davide Stefano Sardina, et al.
Publicado: (2021)